AI-Powered Platform Launch Sparks Nationwide Conversation
The response to OCRA’s launch of the Community Accelerated Research Exchange was immediate and far-reaching. News outlets across the country picked up the story, generating more than 280 media mentions and reaching over 171 million people—a sign of just how much this groundbreaking platform, designed to connect patients, researchers, and data to accelerate gynecologic cancer research, has resonated with the public.
Speaking to 11Alive Atlanta, OCRA’s President & CEO Audra Moran walked through how the platform works.
It includes a registry for women with ovarian and uterine cancer called the Living Lab, where they can contribute their experiences directly and their data—and a Discovery Lab for scientists, powered by Amazon Web Services, where researchers can share data with collaborators around the world in real time.
In Orlando, WESH2 featured Living Lab participant and OCRA Advocate Leader, Lauren Regal, who was diagnosed with ovarian cancer and has since shared her experience through the platform. “I am currently no evidence of disease. My scans are good,” she said. “But it doesn’t change the fact that every day you wake up and you know that ovarian cancer will always be with you.”
Cleveland’s WEWS reported that the platform is designed to help researchers uncover patterns and improve treatments, as more patients share their experiences:
Across the coverage, broadcasters also shared information about OCRA’s free genetic testing program, including the fact that roughly 25% of ovarian cancer cases can be linked to mutations like BRCA1 and BRCA2, making genetic testing an important tool for understanding personal risk.
View more coverage on the launch of OCRA’s Research Exchange on our press page.
